Skip to main content
. 2023 Jan 6;18(1):e0280214. doi: 10.1371/journal.pone.0280214

Fig 3. Representative images of gross lesions after MNU administration in different dosages.

Fig 3

Macroscopic appearance of large mass (white arrows) in the lungs (A, B, C), and thymus (D, E, F) shown in FVB-p53+/- mice of the 25mg/kg (A, D), 50mg/kg (B, E), and 75mg/kg (C, F) group. Splenomegaly (G, H, I) and a large subcutaneous mass (J, K) shown in the FVB-p53+/- mice of the 25mg/kg (G, J), 50mg/kg (H), and 75mg/kg (I, K) group.